Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Nascimbeni

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Expert Review of Gastroenterology & Hepatology|December 12, 2017
Clinical relevance of liver histopathology and different histological classifications of NASH in adultsFabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, et al.
Atherosclerosis|March 16, 2019
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesFabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, et al.
World Journal of Gastroenterology|June 27, 2014
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenAmedeo Lonardo, Luigi Elio Adinolfi, Luciano Restivo, et al.
Journal of Gastroenterology and Hepatology|December 16, 2015
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysisStefano Ballestri, Stefano Zona, Giovanni Targher, et al.
Hepatology (Baltimore, Md.)|March 30, 2019
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research GapsAmedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, et al.
World Journal of Gastroenterology|April 8, 2014
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanismsLuigi E Adinolfi, Rosa Zampino, Luciano Restivo, et al.
Diagnostics (Basel, Switzerland)|January 13, 2021
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver DiseaseStefano Ballestri, Alessandro Mantovani, Enrica Baldelli, et al.
Molecular Genetics and Metabolism|August 18, 2018
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher diseaseFabio Nascimbeni, Elena Cassinerio, Annalisa Dalla Salda, et al.
Andrology|July 10, 2026
The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta-AnalysisGiorgia Spaggiari, Leonardo Dalla Valentina, Cristina Felicani, et al.
BMJ Open Gastroenterology|April 26, 2016
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseFabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Expert Review of Gastroenterology & Hepatology|December 12, 2017
Clinical relevance of liver histopathology and different histological classifications of NASH in adultsFabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, et al.
Atherosclerosis|March 16, 2019
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesFabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, et al.
World Journal of Gastroenterology|June 27, 2014
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenAmedeo Lonardo, Luigi Elio Adinolfi, Luciano Restivo, et al.
Journal of Gastroenterology and Hepatology|December 16, 2015
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysisStefano Ballestri, Stefano Zona, Giovanni Targher, et al.
Hepatology (Baltimore, Md.)|March 30, 2019
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research GapsAmedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, et al.
World Journal of Gastroenterology|April 8, 2014
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanismsLuigi E Adinolfi, Rosa Zampino, Luciano Restivo, et al.
Diagnostics (Basel, Switzerland)|January 13, 2021
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver DiseaseStefano Ballestri, Alessandro Mantovani, Enrica Baldelli, et al.
Molecular Genetics and Metabolism|August 18, 2018
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher diseaseFabio Nascimbeni, Elena Cassinerio, Annalisa Dalla Salda, et al.
Andrology|July 10, 2026
The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta-AnalysisGiorgia Spaggiari, Leonardo Dalla Valentina, Cristina Felicani, et al.
BMJ Open Gastroenterology|April 26, 2016
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseFabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, et al.
Pageof 5